Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
prime scholars

Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 82
  • Journal CiteScore: 35.06
  • Journal Impact Factor: 24.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Volume 23, Issue 11 (2022)

Original Article

Does Erlotinib Restore Chemosensitivity to Chemotherapy in Pancreatic Cancer? A Retrospective Analysis

DOI: 10.35841/1590-8577- 23.11.773

Hypothesis

Clinical Presentations of Rare Pancreatic Neuroendocrine Neoplasms (panNENs)

DOI: 10.35841/1590-8577- 23.11.774

Commentary

Current Treatment Strategy for Intraductal Papillary Mucinous Neoplasms (IPMNs)

DOI: 10.35841/1590-8577- 23.11.775

Expert Review

Clinicopathologic Features and Therapeutic Strategies of this Tumor of the Pancreas

DOI: 10.35841/1590-8577- 23.11.776

Short Communication

Pancreatic Cancer Remains a Deadly Disease. Why?

DOI: 10.35841/1590-8577- 23.11.777

Original Article

Does stenting of pancreaticojejunostomy after pancreatico-duodenectomy mitigate expected complication - Evaluation of a prospective observational study.

  • Muhammad Wasif Saif*, Jyothi Jose, Jeffrey Chi
Awards Nomination
PMC/PubMed Indexed Articles
Google Scholar citation report
Citations : 42521

Journal of the Pancreas received 42521 citations as per Google Scholar report

Citation image
Abstracted/Indexed in
View More
Useful Links
Share This Page
Open Access Journals
View More